LGVN - שווי פעילות לרווח לפני ריבית, מסים ופחת Longeveron

Longeveron Inc. (LGVN) specializes in cellular rejuvenation, utilizing its proprietary Lomecel-B to combat age-related fragility and dementia. The market value dynamics of the asset with the 0.00 indicator reflect the company's current positioning. The R&D center is currently focused on completing Phase II trials for Alzheimer's disease treatments. However, the business faces intense competition for investment and the risk of being displaced by more advanced gene modification methods.

This indicator compares the total value of assets and debt obligations against operating profit before depreciation and amortization, allowing for an assessment of the business's real value without the influence of the tax burden. By analyzing the EV/EBITDA ratio in light of operating profit and depreciation, an investor determines the financial stability of Longeveron Inc. (LGVN) during the implementation of costly robotic systems and the automation of laboratory complexes for precision reagent dosing.